These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 34360586)

  • 1. Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions.
    Tarnacka B; Jopowicz A; Maślińska M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
    Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
    Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration with brain iron accumulation.
    McNeill A; Chinnery PF
    Handb Clin Neurol; 2011; 100():161-72. PubMed ID: 21496576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different cortical excitability profiles in hereditary brain iron and copper accumulation.
    Dubbioso R; Ruggiero L; Esposito M; Tarantino P; De Angelis M; Aruta F; Pappatà S; Ugga L; Piperno A; Iorio R; Santoro L; Iodice R; Manganelli F
    Neurol Sci; 2020 Mar; 41(3):679-685. PubMed ID: 31773358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).
    Schneider SA; Bhatia KP
    J Neural Transm (Vienna); 2013 Apr; 120(4):695-703. PubMed ID: 23212724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.
    Maccarinelli F; Pagani A; Cozzi A; Codazzi F; Di Giacomo G; Capoccia S; Rapino S; Finazzi D; Politi LS; Cirulli F; Giorgio M; Cremona O; Grohovaz F; Levi S
    Neurobiol Dis; 2015 Sep; 81():119-33. PubMed ID: 25447222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic mechanism and modeling of neuroferritinopathy.
    Cozzi A; Santambrogio P; Ripamonti M; Rovida E; Levi S
    Cell Mol Life Sci; 2021 Apr; 78(7):3355-3367. PubMed ID: 33439270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Iron Deposition in Neurodegeneration.
    Dusek P; Hofer T; Alexander J; Roos PM; Aaseth JO
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress.
    Kurzawa-Akanbi M; Keogh M; Tsefou E; Ramsay L; Johnson M; Keers S; Wsa Ochieng L; McNair A; Singh P; Khan A; Pyle A; Hudson G; Ince PG; Attems J; Burn J; Chinnery PF; Morris CM
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):26-42. PubMed ID: 32464705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.
    Salomão RP; Pedroso JL; Gama MT; Dutra LA; Maciel RH; Godeiro-Junior C; Chien HF; Teive HA; Cardoso F; Barsottini OG
    Arq Neuropsiquiatr; 2016 Jul; 74(7):587-96. PubMed ID: 27487380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic delineation of neurodegeneration with brain iron accumulation.
    Gregory A; Polster BJ; Hayflick SJ
    J Med Genet; 2009 Feb; 46(2):73-80. PubMed ID: 18981035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropathology of neurodegeneration with brain iron accumulation.
    Kruer MC
    Int Rev Neurobiol; 2013; 110():165-94. PubMed ID: 24209439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorders of heavy metals.
    Woimant F; Trocello JM
    Handb Clin Neurol; 2014; 120():851-64. PubMed ID: 24365357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aceruloplasminaemia: a disorder of diabetes and neurodegeneration.
    Calder GL; Lee MH; Sachithanandan N; Bell S; Zeimer H; MacIsaac RJ
    Intern Med J; 2017 Jan; 47(1):115-118. PubMed ID: 28076908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of endemic neurodegenerative diseases--a commentary.
    Nishida Y
    Z Naturforsch C J Biosci; 2003; 58(9-10):752-8. PubMed ID: 14577644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential metals in health and disease.
    Jomova K; Makova M; Alomar SY; Alwasel SH; Nepovimova E; Kuca K; Rhodes CJ; Valko M
    Chem Biol Interact; 2022 Nov; 367():110173. PubMed ID: 36152810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.